down arrow

Health.Global

  • Market Cap: Mid Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE075I01017
  • NSEID: HCG
  • BSEID: 539787
INR
530.75
3.75 (0.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 93.52 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

527.35559.90

52 Week

310.10563.15
Valuation
Technical
Day's Volume

CASH

93.52 k (-26.40%) Volume

Shareholding (Dec 2024)

FII

2.77%

Held by 85 FIIs

DII

12.94%

Held by 13 DIIs

Promoter

71.23%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor Management Efficiency with a low ROCE of 5.12%

  • The company has been able to generate a Return on Capital Employed (avg) of 5.12% signifying low profitability per unit of total capital (equity and debt)
2

Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.09 times

3

Healthy long term growth as Operating profit has grown by an annual rate 34.80%

 
4

Flat results in Dec 24

5

Stock is technically in a Bullish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 7,399 Cr (Mid Cap)

stock-summary
P/E

133.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.47

stock-summary
Return on Equity

6.24%

stock-summary
Price to Book

8.53

Revenue and Profits (1 Year):
Net Sales:
559 Cr
(Quarterly Results - Dec 2024)
Net Profit:
7 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
17.77%
0%
17.77%
1 Year
40.52%
0%
40.52%
2 Years
95.74%
0%
95.74%
3 Years
81.52%
0%
81.52%
4 Years
191.46%
0%
191.46%
5 Years
654.98%
0%
654.98%

Health.Global for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.51%
EBIT Growth (5y)
34.80%
EBIT to Interest (avg)
0.82
Debt to EBITDA (avg)
4.92
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.79
Tax Ratio
8.44%
Dividend Payout Ratio
0
Pledged Shares
3.09%
Institutional Holding
15.71%
ROCE (avg)
4.58%
ROE (avg)
2.55%
Valuation key factors
Factor
Value
P/E Ratio
133
Industry P/E
55
Price to Book Value
8.53
EV to EBIT
49.41
EV to EBITDA
23.06
EV to Capital Employed
4.05
EV to Sales
4.04
PEG Ratio
2.38
Dividend Yield
NA
ROCE (Latest)
8.31%
ROE (Latest)
6.24%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

3.0889

Mutual Funds

Held by 9 Schemes (10.04%)

FIIs

Held by 85 FIIs (2.77%)

Promoter with highest holding

Aceso Company Pte. Ltd. (60.35%)

Highest Public shareholder

Tata Mutual Fund - Tata Small Cap Fund (3.35%)

Individual Investors Holdings

9.6%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 18.88% vs 10.64% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 22.46% vs -24.40% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "558.57",
          "val2": "469.87",
          "chgp": "18.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.38",
          "val2": "78.62",
          "chgp": "12.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "40.70",
          "val2": "29.46",
          "chgp": "38.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.98",
          "val2": "5.70",
          "chgp": "22.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.85%",
          "val2": "16.77%",
          "chgp": "-0.92%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 13.88% vs 14.44% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 41.97% vs 57.71% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,079.12",
          "val2": "947.62",
          "chgp": "13.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "193.18",
          "val2": "158.94",
          "chgp": "21.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "69.69",
          "val2": "52.44",
          "chgp": "32.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30.07",
          "val2": "21.18",
          "chgp": "41.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.93%",
          "val2": "16.81%",
          "chgp": "1.12%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.53% vs 13.15% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 37.83% vs 28.18% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,637.69",
          "val2": "1,417.49",
          "chgp": "15.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "281.56",
          "val2": "237.56",
          "chgp": "18.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "110.39",
          "val2": "81.90",
          "chgp": "34.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.05",
          "val2": "26.88",
          "chgp": "37.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.19%",
          "val2": "16.76%",
          "chgp": "0.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 12.85% vs 21.22% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 64.08% vs -45.39% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,912.12",
          "val2": "1,694.44",
          "chgp": "12.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "329.59",
          "val2": "298.68",
          "chgp": "10.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "108.74",
          "val2": "103.50",
          "chgp": "5.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "48.14",
          "val2": "29.34",
          "chgp": "64.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.28%",
          "val2": "17.66%",
          "chgp": "-0.38%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
558.57
469.87
18.88%
Operating Profit (PBDIT) excl Other Income
88.38
78.62
12.41%
Interest
40.70
29.46
38.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.98
5.70
22.46%
Operating Profit Margin (Excl OI)
15.85%
16.77%
-0.92%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 18.88% vs 10.64% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 22.46% vs -24.40% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,079.12
947.62
13.88%
Operating Profit (PBDIT) excl Other Income
193.18
158.94
21.54%
Interest
69.69
52.44
32.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
30.07
21.18
41.97%
Operating Profit Margin (Excl OI)
17.93%
16.81%
1.12%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 13.88% vs 14.44% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 41.97% vs 57.71% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,637.69
1,417.49
15.53%
Operating Profit (PBDIT) excl Other Income
281.56
237.56
18.52%
Interest
110.39
81.90
34.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
37.05
26.88
37.83%
Operating Profit Margin (Excl OI)
17.19%
16.76%
0.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 15.53% vs 13.15% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 37.83% vs 28.18% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,912.12
1,694.44
12.85%
Operating Profit (PBDIT) excl Other Income
329.59
298.68
10.35%
Interest
108.74
103.50
5.06%
Exceptional Items
3.90
0.00
Consolidate Net Profit
48.14
29.34
64.08%
Operating Profit Margin (Excl OI)
17.28%
17.66%
-0.38%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 12.85% vs 21.22% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 64.08% vs -45.39% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Healthcare Global Enterprises Ltd stock-summary
stock-summary
Healthcare Global Enterprises Ltd
Mid Cap
Hospital & Healthcare Services
Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company. The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005. Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006.
Company Coordinates stock-summary
Company Details
HCG Tower No 8 Kalinga Rao Rd, Sampangi Rama Nagar Bangalore Karnataka : 560027
stock-summary
Tel: 91-80-4660-7700
stock-summary
http://www.hcgel.com
stock-summary
sunumanuel@hcgoncology.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."